NR Agarwal Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 19, 2025, 10:00 pm

Competitors of NR Agarwal Industries Ltd

All Competitor Stocks of NR Agarwal Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:35 am

Below is a detailed analysis of the quarterly data for NR Agarwal Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 452.00 Cr.. The value appears to be declining and may need further review. It has decreased from 466.00 Cr. (Mar 2025) to 452.00 Cr., marking a decrease of 14.00 Cr..
• For Expenses, as of Jun 2025, the value is 436.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 438.00 Cr. (Mar 2025) to 436.00 Cr., marking a decrease of 2.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 11.00 Cr..
• For OPM %, as of Jun 2025, the value is 4.00%. The value appears to be declining and may need further review. It has decreased from 6.00% (Mar 2025) to 4.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 25.00 Cr..
• For Interest, as of Jun 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
• For Depreciation, as of Jun 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 13.00 Cr..
• For Tax %, as of Jun 2025, the value is -69.00%. The value appears to be improving (decreasing) as expected. It has decreased from 104.00% (Mar 2025) to -69.00%, marking a decrease of 173.00%.
• For Net Profit, as of Jun 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from -7.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 24.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 9.72. The value appears strong and on an upward trend. It has increased from -4.01 (Mar 2025) to 9.72, marking an increase of 13.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:48 am

Growth

Last Updated: September 5, 2025, 11:25 am

Balance Sheet

Last Updated: June 16, 2025, 11:40 am

Below is a detailed analysis of the balance sheet data for NR Agarwal Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
• For Reserves, as of Mar 2025, the value is 758.00 Cr.. The value appears strong and on an upward trend. It has increased from 743.00 Cr. (Mar 2024) to 758.00 Cr., marking an increase of 15.00 Cr..
• For Borrowings, as of Mar 2025, the value is 644.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 579.00 Cr. (Mar 2024) to 644.00 Cr., marking an increase of 65.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 351.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 227.00 Cr. (Mar 2024) to 351.00 Cr., marking an increase of 124.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,770.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,567.00 Cr. (Mar 2024) to 1,770.00 Cr., marking an increase of 203.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,197.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,135.00 Cr. (Mar 2024) to 1,197.00 Cr., marking an increase of 62.00 Cr..
• For CWIP, as of Mar 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Mar 2024) to 20.00 Cr., marking a decrease of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 101.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2024) to 101.00 Cr., marking an increase of 80.00 Cr..
• For Other Assets, as of Mar 2025, the value is 452.00 Cr.. The value appears strong and on an upward trend. It has increased from 381.00 Cr. (Mar 2024) to 452.00 Cr., marking an increase of 71.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,770.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,567.00 Cr. (Mar 2024) to 1,770.00 Cr., marking an increase of 203.00 Cr..

Notably, the Reserves (758.00 Cr.) exceed the Borrowings (644.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for NR Agarwal Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.37. This value is within the healthy range. It has decreased from 73.72 (Mar 24) to 10.37, marking a decrease of 63.35.
• For Diluted EPS (Rs.), as of Mar 25, the value is 10.37. This value is within the healthy range. It has decreased from 73.72 (Mar 24) to 10.37, marking a decrease of 63.35.
• For Cash EPS (Rs.), as of Mar 25, the value is 48.90. This value is within the healthy range. It has decreased from 95.70 (Mar 24) to 48.90, marking a decrease of 46.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 455.13. It has increased from 446.73 (Mar 24) to 455.13, marking an increase of 8.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 455.13. It has increased from 446.73 (Mar 24) to 455.13, marking an increase of 8.40.
• For Dividend / Share (Rs.), as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 974.80. It has increased from 759.81 (Mar 24) to 974.80, marking an increase of 214.99.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 83.69. This value is within the healthy range. It has decreased from 109.05 (Mar 24) to 83.69, marking a decrease of 25.36.
• For PBIT / Share (Rs.), as of Mar 25, the value is 45.16. This value is within the healthy range. It has decreased from 87.06 (Mar 24) to 45.16, marking a decrease of 41.90.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.38. This value is within the healthy range. It has decreased from 80.87 (Mar 24) to 9.38, marking a decrease of 71.49.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.37. This value is within the healthy range. It has decreased from 73.72 (Mar 24) to 10.37, marking a decrease of 63.35.
• For PBDIT Margin (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 10. It has decreased from 14.35 (Mar 24) to 8.58, marking a decrease of 5.77.
• For PBIT Margin (%), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 10. It has decreased from 11.45 (Mar 24) to 4.63, marking a decrease of 6.82.
• For PBT Margin (%), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 10. It has decreased from 10.64 (Mar 24) to 0.96, marking a decrease of 9.68.
• For Net Profit Margin (%), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 5. It has decreased from 9.70 (Mar 24) to 1.06, marking a decrease of 8.64.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.27. This value is below the healthy minimum of 15. It has decreased from 16.50 (Mar 24) to 2.27, marking a decrease of 14.23.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.55. This value is below the healthy minimum of 10. It has decreased from 11.05 (Mar 24) to 5.55, marking a decrease of 5.50.
• For Return On Assets (%), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 5. It has decreased from 8.00 (Mar 24) to 0.99, marking a decrease of 7.01.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.64. This value is within the healthy range. It has increased from 0.58 (Mar 24) to 0.64, marking an increase of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.80. This value is within the healthy range. It has increased from 0.72 (Mar 24) to 0.80, marking an increase of 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. There is no change compared to the previous period (Mar 24) which recorded 0.99.
• For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has decreased from 1.61 (Mar 24) to 1.33, marking a decrease of 0.28.
• For Quick Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. It has increased from 0.86 (Mar 24) to 0.89, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.85. This value exceeds the healthy maximum of 8. It has increased from 4.83 (Mar 24) to 9.85, marking an increase of 5.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.28. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 19.28, marking an increase of 19.28.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.08. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 4.08, marking an increase of 4.08.
• For Earning Retention Ratio (%), as of Mar 25, the value is 80.72. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 80.72, marking an increase of 80.72.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.92. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 95.92, marking an increase of 95.92.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.34. This value is below the healthy minimum of 3. It has decreased from 17.60 (Mar 24) to 2.34, marking a decrease of 15.26.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 3. It has decreased from 12.90 (Mar 24) to 1.29, marking a decrease of 11.61.
• For Enterprise Value (Cr.), as of Mar 25, the value is 997.37. It has decreased from 1,270.11 (Mar 24) to 997.37, marking a decrease of 272.74.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.60, marking a decrease of 0.38.
• For EV / EBITDA (X), as of Mar 25, the value is 7.00. This value is within the healthy range. It has increased from 6.84 (Mar 24) to 7.00, marking an increase of 0.16.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 1. It has decreased from 0.56 (Mar 24) to 0.22, marking a decrease of 0.34.
• For Retention Ratios (%), as of Mar 25, the value is 80.71. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 80.71, marking an increase of 80.71.
• For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.48, marking a decrease of 0.48.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 1. It has decreased from 0.56 (Mar 24) to 0.22, marking a decrease of 0.34.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.17 (Mar 24) to 0.04, marking a decrease of 0.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness